Exploring Connections between Oral Microbiota, Short-Chain Fatty Acids, and Specific Cancer Types: A Study of Oral Cancer, Head and Neck Cancer, Pancreatic Cancer, and Gastric Cancer
暂无分享,去创建一个
I. Choi | S. Woo | K. Ryu | Yuh-Seog Jung | S. Myung | Sang-Jae Park | Woojin Lee | Z. Nouri | S. Choi | Joo-Yong Park | Wonyoung Choi | Mi Kyung Kim | Jong-Ho Lee | Zeba Praveen | Yun Jung Woo | Jin-Hee Park
[1] Yusuf Alan,et al. Postbiotic metabolites, antioxidant and anticancer activities of probiotic Leuconostoc pseudomesenteroides strains in natural pickles , 2022, Archives of Microbiology.
[2] Li V. Yang,et al. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications , 2022, Cells.
[3] E. Franz,et al. Bacterial and Parasitic Pathogens as Risk Factors for Cancers in the Gastrointestinal Tract: A Review of Current Epidemiological Knowledge , 2021, Frontiers in Microbiology.
[4] D. Frank,et al. A Dysbiotic Microbiome Promotes Head and Neck Squamous Cell Carcinoma , 2021, Oncogene.
[5] T. Karpiński,et al. The Oral Microbiota and its Role in Carcinogenesis. , 2021, Seminars in cancer biology.
[6] M. Assafi,et al. The association between body mass index and the oral Firmicutes and Bacteroidetes profiles of healthy individuals. , 2021, Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia.
[7] A. Hackshaw,et al. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK , 2021, British Journal of Cancer.
[8] A. A. Khan,et al. Microbiota and cancer: current understanding and mechanistic implications , 2021, Clinical and Translational Oncology.
[9] Xuefeng Gao,et al. Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study , 2021, Frontiers in Cellular and Infection Microbiology.
[10] S. Bakhti,et al. Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next? , 2021, BMC microbiology.
[11] H. Tuominen,et al. Oral Microbiota and Cancer Development , 2020, Pathobiology.
[12] Dae Hyun Lee,et al. Abiotrophia and Granulicatella Infections in Cancer Patients: A Single-Center Chart Review Study , 2020, Journal of Microbiology and Infectious Diseases.
[13] P. Ferrante,et al. The Obesity-Related Gut Bacterial and Viral Dysbiosis Can Impact the Risk of Colon Cancer Development , 2020, Microorganisms.
[14] György Kovács,et al. Smote-variants: A python implementation of 85 minority oversampling techniques , 2019, Neurocomputing.
[15] György Kovács,et al. An empirical comparison and evaluation of minority oversampling techniques on a large number of imbalanced datasets , 2019, Appl. Soft Comput..
[16] Michael W. Kattan,et al. A comprehensive data level analysis for cancer diagnosis on imbalanced data , 2019, J. Biomed. Informatics.
[17] G. Sethi,et al. Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression. , 2018, Cancer letters.
[18] Yulong Yin,et al. Implication of G Protein-Coupled Receptor 43 in Intestinal Inflammation: A Mini-Review , 2018, Front. Immunol..
[19] Patrice D Cani,et al. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer , 2018, Nature Reviews Gastroenterology & Hepatology.
[20] Zhongtao Zhang,et al. A screening method for gastric cancer by oral microbiome detection. , 2018, Oncology reports.
[21] R. Hayes,et al. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer , 2018, JAMA oncology.
[22] Jennifer R. Grandis,et al. Targeting the IL-6/JAK/STAT3 signalling axis in cancer , 2018, Nature Reviews Clinical Oncology.
[23] A. Barzegari,et al. Leuconostoc mesenteroides-derived anticancer pharmaceuticals hinder inflammation and cell survival in colon cancer cells by modulating NF-κB/AKT/PTEN/MAPK pathways. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[24] Apolinaria García,et al. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle. , 2016, Journal of medical microbiology.
[25] R. Hayes,et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study , 2016, Gut.
[26] Shuwen Han,et al. Potential screening and early diagnosis method for cancer: Tongue diagnosis , 2016, International journal of oncology.
[27] Ya-Wen Gou,et al. Association between alcohol intake and the risk of pancreatic cancer: a dose–response meta-analysis of cohort studies , 2016, BMC Cancer.
[28] Hongwei Cheng,et al. Oral Microbiota and Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Area of China , 2015, PloS one.
[29] A. Ichimura,et al. Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation , 2015, Nutrients.
[30] Adam B. Olshen,et al. Changes in Abundance of Oral Microbiota Associated with Oral Cancer , 2014, PloS one.
[31] R. Lamont,et al. Oral Bacteria and Cancer , 2014, PLoS pathogens.
[32] A. Astrup,et al. Is butyrate the link between diet, intestinal microbiota and obesity‐related metabolic diseases? , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[33] D. Devine,et al. Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics , 2013, Clinical, cosmetic and investigational dentistry.
[34] G. Ginsburg,et al. The oral microbiome in health and disease and the potential impact on personalized dental medicine. , 2012, Oral diseases.
[35] R. Hafidh,et al. The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role , 2011, Journal of experimental & clinical cancer research : CR.
[36] P. Chaturvedi,et al. The role of bacteria in oral cancer , 2010, Indian Journal of Medical and Paediatric Oncology.
[37] G. Cresci,et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. , 2009, Cancer research.
[38] M. Posner,et al. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects , 2005, Journal of Translational Medicine.
[39] S. Kimura,et al. Streptococcus anginosus infection in oral cancer and its infection route. , 2005, Oral diseases.
[40] N. Hanada,et al. Molecular analysis of age-related changes of Streptococcus anginosus group and Streptococcus mitis in saliva. , 2004, Oral microbiology and immunology.
[41] B. Evers,et al. Butyrate inhibits pancreatic cancer invasion , 2003, Journal of Gastrointestinal Surgery.
[42] N. Weiss,et al. An exploration of the periodontitis-cancer association. , 2003, Annals of epidemiology.
[43] C. Harris,et al. Radical causes of cancer , 2003, Nature Reviews Cancer.
[44] G. Corrao,et al. A meta-analysis of alcohol drinking and cancer risk , 2001, British Journal of Cancer.
[45] Y. Nakanishi,et al. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. , 1998, Cancer research.
[46] H. Newman,et al. The microflora associated with human oral carcinomas. , 1998, Oral oncology.
[47] P. Holmstrup,et al. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. , 1987, Carcinogenesis.
[48] Ruth Etzioni,et al. Early detection: The case for early detection , 2003, Nature Reviews Cancer.
[49] H. Ludwig,et al. Interleukin-6 is a prognostic factor in multiple myeloma. , 1991, Blood.